2-Methyl-5-(pyridin-2-yl)aniline

Catalog No.: 
ACPCQE679
CAS No.: 
857221-89-7
Molecular Formula: 
C12H12N2
Molecular Weight: 
184.24
2-Methyl-5-(pyridin-2-yl)aniline structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$126.00In stockInquiry
100mg95%$197.00In stockIn stock
250mg95%$384.00In stockIn stock
1g95%$1075.00In stockIn stock
5g95%$2185.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Methyl-5-(pyridin-2-yl)aniline
IUPAC Name2-methyl-5-(pyridin-2-yl)aniline
MDL No.MFCD18855398
Molecular FormulaC12H12N2
Molecular Weight184.24
SMILESNC1=CC(C2=NC=CC=C2)=CC=C1C
InChI KeyLBKPLWQTEXXBGC-UHFFFAOYSA-N
SynonymBenzenamine, 2-methyl-5-(2-pyridinyl)-;2-Methyl-5-(pyridin-2-yl)aniline
CAS No.857221-89-7

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H312-H315-H319-H332-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACPCQE679 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACVSZO761 route compound structure diagram
    ACVSZO76139478-78-9In Stock
  2. Plus
  3. ACOJZD165 route compound structure diagram
    ACOJZD165197958-29-5In Stock
  4. Then
  5. ACPCQE679 route product structure diagram
    ACPCQE679857221-89-7In Stock
Inquiry

2. ACPCQE679 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACPCQE679 route product structure diagram
    ACPCQE679857221-89-7In Stock
Inquiry

3. ACPCQE679 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACPCQE679 route product structure diagram
    ACPCQE679857221-89-7In Stock
Inquiry

Comments (0)